# Janssen Pharmaceuticals Inc., Raritan, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/janssen-pharmaceuticals-inc/b494dc6e-cfeb-46a2-8c10-e036e6a5a623

> Inspection records and compliance data for Janssen Pharmaceuticals Inc. in Raritan, New Jersey. 10 FDA inspections on record, 2 Form 483s, last inspected November 01, 2024.

---

## Details

- Name: Janssen Pharmaceuticals Inc.
- FEI Number: 2211100
- Address Line 1: 1000 U.S. Route 202 South
- City: Raritan
- State: New Jersey
- Zip Code: 08869
- Country Name: United States
- Address: 1000 U.S. Route 202 South, Raritan, New Jersey 08869, United States
- Country: United States

## Related Documents

- [483 - Janssen Pharmaceuticals Inc. - Unknown Date](https://www.keypedia.com/records/483/janssen-pharmaceuticals-inc/82d909e3-7138-4083-bfb4-4a18fd99a0de) — source: FDA, date: Invalid Date
- [483 - Janssen Pharmaceuticals Inc. - 2024-11-01](https://www.keypedia.com/records/483/janssen-pharmaceuticals-inc/c40451a8-d847-46c1-a926-afe9ac6ef998) — source: FDA, date: November 1, 2024
- [FDA Inspection 1252007 - Janssen Pharmaceuticals Inc. - 2024-11-01](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/6cf9b413-b5b9-41ea-a1db-605ee18bf2ee) — source: FDA, date: November 1, 2024
- [483 - Janssen Pharmaceuticals Inc. - 2023-12-14](https://www.keypedia.com/records/483/janssen-pharmaceuticals-inc/c421012f-38e2-4ef0-8f9f-cd8d3bea7155) — source: FDA, date: December 14, 2023
- [FDA Inspection 1225275 - Janssen Pharmaceuticals Inc. - 2023-12-14](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/f5eb5852-3f6a-4246-a387-cf35044c8d21) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 14, 2023
- FDA Inspection 1175643 - Janssen Pharmaceuticals Inc. - 2022-06-17 — classification: No Action Indicated (NAI), source: FDA, date: June 17, 2022
- [EIR - Janssen Pharmaceuticals Inc. - 2017-01-26](https://www.keypedia.com/records/eir/janssen-pharmaceuticals-inc/fed9a86c-cfbf-4828-8cff-03af0ab8f204) — source: FDA, date: January 26, 2017
- FDA Inspection 998113 - Janssen Pharmaceuticals Inc. - 2017-01-26 — classification: No Action Indicated (NAI), source: FDA, date: January 26, 2017
- [EIR - Janssen Pharmaceuticals Inc. - 2016-01-22](https://www.keypedia.com/records/eir/janssen-pharmaceuticals-inc/dd60c4ef-b539-4787-970f-aaf394f66a84) — source: FDA, date: January 22, 2016
- FDA Inspection 965139 - Janssen Pharmaceuticals Inc. - 2016-01-22 — classification: No Action Indicated (NAI), source: FDA, date: January 22, 2016
- FDA Inspection 833775 - Janssen Pharmaceuticals Inc. - 2013-05-21 — classification: No Action Indicated (NAI), source: FDA, date: May 21, 2013
- FDA Inspection 787093 - Janssen Pharmaceuticals Inc. - 2012-06-19 — classification: No Action Indicated (NAI), source: FDA, date: June 19, 2012
- FDA Inspection 740773 - Janssen Pharmaceuticals Inc. - 2011-08-22 — classification: No Action Indicated (NAI), source: FDA, date: August 22, 2011
- FDA Inspection 674432 - Janssen Pharmaceuticals Inc. - 2010-08-06 — classification: No Action Indicated (NAI), source: FDA, date: August 6, 2010
- FDA Inspection 556188 - Janssen Pharmaceuticals Inc. - 2009-01-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 15, 2009

## Related Companies

- [Pfizer Manufacturing Belgium NV](https://www.keypedia.com/companies/pfizer-manufacturing-belgium-nv/9251b625-0cd3-4c3e-8267-f0c88fe32d75)
- [Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg-ravensburg-mooswiesen/d0287c3d-c544-40de-aece-ba713025286c)
- [Bora Pharmaceuticals Injectables Inc](https://www.keypedia.com/companies/bora-pharmaceuticals-injectables-inc/d6e15b21-41fb-4f18-9638-893d3f44fcd1)
- [Kenvue Brands LLC](https://www.keypedia.com/companies/kenvue-brands-llc/69c27fd1-bbb9-4c3a-bbb5-4ac86be8e574)
- [CoreRX Inc.](https://www.keypedia.com/companies/corerx-inc/cca4f858-9ccd-498a-893b-22c5d29559aa)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/6b5864ed-07a2-4861-b424-021018d4f7e9)
- [DPT Laboratories Ltd](https://www.keypedia.com/companies/dpt-laboratories-ltd/b2d45aa5-6cf4-4401-87a2-35470321dc30)
- [Eli Lilly and Company](https://www.keypedia.com/companies/eli-lilly-and-company/3ee60880-ca28-4c3e-a630-512617af2daa)
- [Gland Pharma Limited, Units I+II Pashamylaram Site](https://www.keypedia.com/companies/gland-pharma-limited-units-iii-pashamylaram-site/a7dffca3-c5cc-4802-9cab-54995e7133ca)
- [Afton Scientific, LLC](https://www.keypedia.com/companies/afton-scientific-llc/e5ec92fc-2eb5-4366-8d78-fd597c977fe8)

## Related Officers

- [investigator](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)
- [Drug Investigator](https://www.keypedia.com/people/paul-l-bellamy/e94e1ff9-0772-4c1f-af99-a8298983e2f4)
- [Laurel A. Beer](https://www.keypedia.com/people/laurel-a-beer/0ac1e74f-0ff6-4db6-a0e8-0c3fb013720e)
- [Investigator](https://www.keypedia.com/people/thai-d-truong/7395c128-0adb-44a1-8831-64673c98e93d)